Formulated for rheumatoid arthritis and psoriasis to manage inflammatory symptoms and support disease remission.
Mechanism of Action
Methotrexate irreversibly binds to dihydrofolate reductase, inhibiting the synthesis of thymidylate and purine nucleotides. This stops DNA synthesis and cellular replication in rapidly dividing cells.
Information related to Rheumatrex is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
